copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Ascendis Pharma: Patients. Science. Passion. Our unwavering focus Ascendis Pharma is a global biopharmaceutical company committed to making a meaningful difference in patients’ lives
About Us - Ascendis Pharma Ascendis Pharma was founded in 2007 based on the innovative TransCon technology platform We are headquartered in Copenhagen, Denmark and are publicly traded, following an initial public offering in 2015 (Nasdaq: ASND) We have employees working across the globe to improve patients’ lives
Pipeline - Ascendis Pharma Our pipeline of innovative new therapies is driven by the flexibility of our TransCon technologies and our aim to improve patients' lives Ascendis and its partners have multiple prodrug therapies in development Each product candidate is unique and designed to be a best-in-class therapy
OUR PRODUCTS - Ascendis Pharma Ascendis Pharma medicines using TransCon technology are authorized for the indications and in the countries or regions shown below Please note that in some countries, a medicine may be authorized for marketing but not yet commercially available
Contact Us - Ascendis Pharma Ascendis is headquartered in Denmark and has offices in Germany and in Palo Alto, CA , Princeton, NJ in the U S
Leadership | Ascendis Pharma He currently serves on the boards of Ascendis Pharma A S (NASDAQ: ASND) and KalVista Pharmaceuticals (NASDAQ: KALV), and has previously served on the boards of Aclaris Therapeutics (NASDAQ: ACRS), Biohaven Pharmaceuticals (NYSE: BHVN), and many other private and public biopharmaceutical companies
Careers | Ascendis Pharma As Ascendis grows, we are always looking to connect with individuals who are passionate about making a meaningful difference for patients If you don’t see an open role that fits your skills and would like to be considered for future opportunities, we encourage you to upload your resume to our country-specific talent pools listed here:
Endocrinology | Ascendis Pharma Consistent with our strategic roadmap for growth, we plan to further grow these candidates through label expansion and global clinical reach, either directly or through partnerships Our science aims to make a difference for patients, caregivers, and healthcare providers as we build a potentially best-in-class endocrinology rare disease portfolio
Technology - Ascendis Pharma At the core of Ascendis Pharma is a powerful, flexible technology platform that uses advanced knowledge of chemistry to overcome challenges of developing new therapeutics When applied using known biology, this technology platform helps us address unmet patient needs in unprecedented ways
Ascendis Pharma A S YORVIPATH’s titration scheme was only evaluated in adults who first achieved an albumin-corrected serum calcium of at least 7 8 mg dL using calcium and active vitamin D treatment